CCL24 as a diagnostic and therapeutic target for breast cancer
US11988672B2 · kind B2 · utility
0Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 24, 2020 |
| Grant date | May 21, 2024 |
| Priority date | — |
| Expiry date | Jan 17, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/521
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Using expression of CC chemokine ligand (CCL24) to serve as an identification of a potential deriver of metastatic cancers and methods of detecting the presence of CCL24 to serve as a breast cancer diagnosis tool.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.